Nuclear Medicine and Biology

Papers
(The TQCC of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
An approach towards reverse generator system for 99mTc separation from LSA 99Mo63
Preparation of electrodeposited UO2 target for fission-99Mo production62
Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals.43
[18F]Talazoparib: a novel potential PET imaging agent of PARP39
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers32
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism26
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors23
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics23
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter23
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging22
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry19
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation19
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7419
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.19
PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models17
Status of radiobiology in molecular radionuclide therapy – Hope for the future17
Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India17
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks15
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18814
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy14
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6414
Simple method for the production of [11C]phosgene14
Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-6413
Copper-mediated 18F-fluorination of boroxines: a systematic optimization study13
Synthesis of [11C]Me-DPA and evaluation in transgenic mouse model of Alzheimer’s disease13
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes12
Transition-metal-free reductive coupling of an 18F-labeled nitro-arene with boronic acids as a potential access to 18F-labeled fenamates12
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/12
Radiolabeling yield dependency of post-dry distillation decay of astatine-21111
Editorial Board11
Enhancing the accumulation level of 3-[18F]fluoro-L-α-methyltyrosine in tumors by preloading probenecid10
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH10
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N10
MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons10
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody10
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response10
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen10
The first radioiodinated protein affinity probe for estrogen receptor targeted breast cancer imaging9
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies9
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide9
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt9
Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer9
A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease8
Author Index8
Mitochondria-targeted radiocomplexes for cancer theranostics8
68Ge/68Ga-generator: a radionuclide source or an approved drug?8
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron8
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo7
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours7
Next generation copper complexes for efficient production of radiolabeled aromatics7
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE7
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM37
Editorial Board7
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor7
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor6
What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals6
Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis6
Non-invasive imaging of neutrophils in acute sepsis6
[89Zr]ZrTrastuzumab automatic preparation on commercial cassette base synthesis module6
Site-selective 18F-labelling of octreotide via disulfide rebridging6
Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A96
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide6
Translation of [68Ga]Ga-PSMA-11 radiosynthesis on the microfluidic system iMiDEVTM6
Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain6
[68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging6
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information5
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study5
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages5
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results5
A decade of ubiquicidin development for PET imaging of infection: A systematic review5
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu5
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far5
Editorial Board5
Rhenium and technetium complexes in extremely low oxidation states5
Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate4
Editorial Board4
Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach4
Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer4
Comparison of biodistribution according to administration route for the development of liposome therapeutics4
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma4
Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals4
Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model4
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 24
Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides4
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study4
Abstract withdrawn.4
A multi-modality platform employing supramolecular chemistry to radiolabel antibodies4
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer4
Current developments in the production of actinium-225 from thorium-2293
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 13
Title Page3
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne3
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP13
Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis3
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging3
Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction3
Brain energetics by biomedical modalities3
Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging3
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer3
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging3
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity3
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production3
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold3
Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents2
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase2
Preliminary evaluation of 124I labeled virus receptor binding domain2
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist2
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform2
Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery2
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction2
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry2
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy2
Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans2
Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain2
Radioactive Isotopes for Cancer Radiotherapy2
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET2
Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers2
Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R)2
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation2
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN2
Scale up production and purification of high specific activity lead-203 (203Pb)2
Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma2
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?2
8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor2
Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging2
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids2
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB2
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu2
Development of small molecule PET-tracers targeting PD-L12
Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module2
Quality assessment of cyclotron-produced 67Cu2
Development of Astatine-211 labeling reaction using aryliodonium ylide2
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands2
Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers2
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors2
Editorial Board2
Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS1
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience1
Development of a stabilized GRPR antagonist for targeted cancer theranostics1
In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast canc1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes1
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM1
Editorial Board1
Synthesis of radiopharmaceuticals (At-AITM) for melanoma with overexpressed metabotropic glutamate receptor 11
AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions1
CONTENTS1
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors1
Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation1
Long term experience in [11C]UCB-J production in Turku PET Centre1
Improving the quality of Ga radionuclides to achieve high radiolabeling yields1
[177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors1
Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform1
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors1
Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process1
Synthesis of PET tracers for imaging of thiocyanate efflux from the brain1
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer1
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives1
Biologicals as theranostic vehicles in paediatric oncology1
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production1
Thiacrown Ligands for Encapsulation of Mercury-197 m/g into Radiopharmaceuticals1
Influence of radiolysis on astatine-211 chemistry1
68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents1
Synthesis of a new 6-substituted 4-anilinoquinazoline derivative as irreversible inhibitor for EGFR imaging1
Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging1
Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours1
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells1
Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists1
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M21
Editorial Board1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl1
Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis1
Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor1
ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET1
Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 d1
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci1
Synthesis and radiofluorination of [18F]F-BAY-8002: a novel potential radiotracer for PET imaging of monocarboxylate transporter 11
A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben1
In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK62401
Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections1
Laminated holmium-166-containing electrospun bandages for use against skin cancer1
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics1
Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation1
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors1
Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure1
In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor1
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors1
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG1
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications1
New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy1
Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases1
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations1
Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker1
In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies1
Subtype-selective vasopressin 1A receptor imaging by positron emission tomography1
Utilizing click chemistry for PET infection imaging by fluorine-18 labeling of azide-modified bacteria1
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma1
Synthesis, radiolabeling and biological evaluation of a novel trace amine-associated receptor 1 (TAAR1) PET radioligand1
Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography1
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR41
Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation0
Development of a 99mTc-NTP 15-5 kit for an early clinical trial0
Tumor stroma diagnostic imaging by a 68Ga-coupled small-molecule fibroblast activation protein (FAP) inhibitor: first pre-clinical data0
Synthesis of [64Cu]Cu+ complex for redox imaging and evaluation of its reactivity with reactive oxygen species0
Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers0
Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit0
Preparation and preclinical evaluation of novel 18F-labeled FAP ligands0
Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives0
Investigation into metabolic profile of [11C]Me-DPA0
Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC)0
[18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling0
A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair0
Antibody-based PET imaging of alpha-synuclein0
Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor0
Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging0
Synthesis and radiolabeling of [11C]CP31398 and fluorine-18 derivatives for PET imaging targeting p530
Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors0
Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy0
Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT0
Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B0
Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy0
Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers0
[18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate0
Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology0
Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M40
Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer0
Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors0
Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer0
Synthesis, radiolabeling and metabolism of new fluorine-18 derivatives of MeDAS for PET imaging of demyelination0
Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules0
64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging0
Synthesis, characterization and biodistribution of a new ‘2+1’ 99mTc/Re tricarbonyl complex bearing bis(2-hydroxyethyl) carbamodithioate and 4-anilinoquinazoline derivative0
Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies0
Synthesis of N-methyl- and 5-OH-[18F]fluorotryptophans0
Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model0
Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals0
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC0
0.10234594345093